(Reuters) – Moderna Inc said on Monday it generated about $18.4 billion in COVID-19 vaccine sales in 2022.
(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)
Moderna generates $18.4 billion in COVID vaccine sales in 2022
FILE PHOTO: A sign marks the headquarters of Moderna in Cambridge